Pol, J. G., Checcoli, A., Lizarralde-Guerrero, M., & Kroemer, G. RIPK1 inhibition in malignant cells potentiates immunotherapy and radiotherapy outcome. Taylor & Francis Group.
Chicago Style (17th ed.) CitationPol, Jonathan G., Andrea Checcoli, Manuela Lizarralde-Guerrero, and Guido Kroemer. RIPK1 Inhibition in Malignant Cells Potentiates Immunotherapy and Radiotherapy Outcome. Taylor & Francis Group.
MLA (9th ed.) CitationPol, Jonathan G., et al. RIPK1 Inhibition in Malignant Cells Potentiates Immunotherapy and Radiotherapy Outcome. Taylor & Francis Group.
Warning: These citations may not always be 100% accurate.